The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.
|Condition||Endometrial Cancer Stage I|
|Clinical Study Identifier||NCT04792749|
|Sponsor||Samsung Medical Center|
|Last Modified on||4 October 2021|
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
No annotations made yet
Congrats! You have your own personal workspace now.